Quick navigation menu :

  1. Go to the content
  2. Go to main section's menu
  3. Go to Search tool
  4. Go to Help menu
  5. Go to modules
  6. Go to the list of keyboard shortcuts

This site uses cookies to store information on your computer. Some cookies on this site are essential and the site won’t work as expected without them. To learn more about cookies and their benefits, please view our cookies policy. You could also decide what kind of cookie the website could use or not use on our cookies settings page.
By closing this message or navigating within the website, you consent to our use of cookies on this device in accordance with our cookie policy unless you have disabled them.

Help menu :

  1. Sanofi Worldwide |
  2. Our UK Websites |
  3. Global Business Websites |
  4. Contact us |
  5. Site map |
  6. Help
  1. RSS
  2. Font size

    Reduce font size Increase font size  

Our Activities

Content :


February 11, 2015

Sanofi has accelerated its diversification strategy in the generics market to meet the needs of as many patients worldwide as possible.


Building a stronger presence in the field of branded generic medicines is an important part of our growth strategy.  We have expanded our portfolio with major acquisitions in generics, including Zentiva which has become the group's European generics platform.  Focusing on the needs of patients, we adopt a regional approach in order to make more of our products more affordable and available to more patients.

Module :

Corporate Information

Corporate Information